A phase IV Study to Evaluate the Safety and Effectiveness of Sofosbuvir-containing Treatment Regimens in Patients with Chronic Hepatitis C Virus (HCV) Infection in a Chinese Real-World Setting
Latest Information Update: 21 Dec 2020
At a glance
- Drugs Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions
- 02 Dec 2020 New trial record